Inclusion Criteria:  history of stage I, ER and/or PR positive, her2neu negative breast cancer 12-36 months from diagnosis at the time of the survey assessment (for both REASSURE cohorts 1 and 2). For REASSURE cohort 1, this will translate into being 6-18 months from diagnosis at the time they are approached for the study. receiving follow-up for their breast cancer with a University of Wisconsin (UW) Breast Center medical oncologist participating in the REASSURE pilot study ability to complete the PRO assessment online English speaker  Exclusion Criteria:  receipt of chemotherapy non-English speakers pregnancy cancer recurrence (local, regional or distant) since the initial diagnosis